Cáncer sin quimioterapia: una revolución silenciosa
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
A growing number of cancer patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.
No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.
No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening.
Shots: Chi-Med initiated the filing of NDA to the US FDA for surufatinib to treat pancreatic & non-pancreatic NET & plans to complete the NDA […]
Shots: The US FDA approved FoundationOneCDx to be used as a CDx for Vitrakvi (larotrectinib) to identify patients with NTRK fusions across all solid tumors. […]
This content is password protected. To view it please enter your password below: Password:
Copyright © 2024 | WordPress Theme by MH Themes